GlassScriptPhysician profile
Ashley E Akhtar
NPI 1801216064
$826.85
in general payments reported to CMS, 2019-2025
16 companies · $70.71 in 2025
The $70.71 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.11 · 2022: $297 · 2023: $322 · 2024: $91.78 · 2025: $70.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.00 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $185.99 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $150.12 | 2023-2024 | Veozah |
| Abbvie INC. | $94.48 | 2022-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $75.21 | 2022-2023 | Slynd |
| Evofem Biosciences, INC. | $65.93 | 2021-2022 | |
| Myovant Sciences INC. | $50.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.17 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $32.23 | 2023-2024 | Myfembree |
| Baxter Healthcare | $32.13 | 2023 | Perclot |
| Dexcom, INC. | $20.15 | 2024 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $14.37 | 2021 | |
| Pfizer INC. | $13.99 | 2023 | |
| Agile Therapeutics, INC. | $13.55 | 2021 | |
| Mayne Pharma Commercial LLC | $13.06 | 2025 | |
| Therapeuticsmd, INC. | $12.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $6.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.